Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PD-1 and PDL-1 Inhibitors
1.2 Key Market Segments
1.2.1 PD-1 and PDL-1 Inhibitors Segment by Type
1.2.2 PD-1 and PDL-1 Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 and PDL-1 Inhibitors Market Overview
2.1 Global Market Overview
2.1.1 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global PD-1 and PDL-1 Inhibitors Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 and PDL-1 Inhibitors Market Competitive Landscape
3.1 Global PD-1 and PDL-1 Inhibitors Sales by Manufacturers (2019-2025)
3.2 Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Manufacturers (2019-2025)
3.3 PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PDL-1 Inhibitors Average Price by Manufacturers (2019-2025)
3.5 Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites, Area Served, Product Type
3.6 PD-1 and PDL-1 Inhibitors Market Competitive Situation and Trends
3.6.1 PD-1 and PDL-1 Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PDL-1 Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 and PDL-1 Inhibitors Industry Chain Analysis
4.1 PD-1 and PDL-1 Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PD-1 and PDL-1 Inhibitors Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 and PDL-1 Inhibitors Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2025)
6.3 Global PD-1 and PDL-1 Inhibitors Market Size Market Share by Type (2019-2025)
6.4 Global PD-1 and PDL-1 Inhibitors Price by Type (2019-2025)
7 PD-1 and PDL-1 Inhibitors Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PDL-1 Inhibitors Market Sales by Application (2019-2025)
7.3 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Application (2019-2025)
7.4 Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2025)
8 PD-1 and PDL-1 Inhibitors Market Consumption by Region
8.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PDL-1 Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PDL-1 Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PDL-1 Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PD-1 and PDL-1 Inhibitors Market Production by Region
9.1 Global Production of PD-1 and PDL-1 Inhibitors by Region (2019-2025)
9.2 Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Region (2019-2025)
9.3 Global PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America PD-1 and PDL-1 Inhibitors Production
9.4.1 North America PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.4.2 North America PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe PD-1 and PDL-1 Inhibitors Production
9.5.1 Europe PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.5.2 Europe PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan PD-1 and PDL-1 Inhibitors Production (2019-2025)
9.6.1 Japan PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.6.2 Japan PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China PD-1 and PDL-1 Inhibitors Production (2019-2025)
9.7.1 China PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.7.2 China PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
10.1.2 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
10.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Market Performance
10.1.4 GlaxoSmithKline plc Business Overview
10.1.5 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
10.1.6 GlaxoSmithKline plc Recent Developments
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
10.2.2 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
10.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Market Performance
10.2.4 Bristol-Myers Squibb Company Business Overview
10.2.5 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
10.2.6 Bristol-Myers Squibb Company Recent Developments
10.3 Arcus Biosciences
10.3.1 Arcus Biosciences PD-1 and PDL-1 Inhibitors Basic Information
10.3.2 Arcus Biosciences PD-1 and PDL-1 Inhibitors Product Overview
10.3.3 Arcus Biosciences PD-1 and PDL-1 Inhibitors Product Market Performance
10.3.4 Arcus Biosciences PD-1 and PDL-1 Inhibitors SWOT Analysis
10.3.5 Arcus Biosciences Business Overview
10.3.6 Arcus Biosciences Recent Developments
10.4 Inc.
10.4.1 Inc. PD-1 and PDL-1 Inhibitors Basic Information
10.4.2 Inc. PD-1 and PDL-1 Inhibitors Product Overview
10.4.3 Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
10.4.4 Inc. Business Overview
10.4.5 Inc. Recent Developments
10.5 Agenus Inc
10.5.1 Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
10.5.2 Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
10.5.3 Agenus Inc PD-1 and PDL-1 Inhibitors Product Market Performance
10.5.4 Agenus Inc Business Overview
10.5.5 Agenus Inc Recent Developments
10.6 F. Hoffmann-La Roche Ltd
10.6.1 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
10.6.2 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
10.6.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
10.6.4 F. Hoffmann-La Roche Ltd Business Overview
10.6.5 F. Hoffmann-La Roche Ltd Recent Developments
10.7 Astra Zeneca PLC
10.7.1 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
10.7.2 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
10.7.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Market Performance
10.7.4 Astra Zeneca PLC Business Overview
10.7.5 Astra Zeneca PLC Recent Developments
10.8 Beigene Ltd
10.8.1 Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
10.8.2 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
10.8.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
10.8.4 Beigene Ltd Business Overview
10.8.5 Beigene Ltd Recent Developments
10.9 Incyte Corporation
10.9.1 Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
10.9.2 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
10.9.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Market Performance
10.9.4 Incyte Corporation Business Overview
10.9.5 Incyte Corporation Recent Developments
10.10 Biocad
10.10.1 Biocad PD-1 and PDL-1 Inhibitors Basic Information
10.10.2 Biocad PD-1 and PDL-1 Inhibitors Product Overview
10.10.3 Biocad PD-1 and PDL-1 Inhibitors Product Market Performance
10.10.4 Biocad Business Overview
10.10.5 Biocad Recent Developments
10.11 CStone Pharmaceuticals
10.11.1 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
10.11.2 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
10.11.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Market Performance
10.11.4 CStone Pharmaceuticals Business Overview
10.11.5 CStone Pharmaceuticals Recent Developments
10.12 Ono Pharmaceutical
10.12.1 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
10.12.2 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
10.12.3 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Market Performance
10.12.4 Ono Pharmaceutical Business Overview
10.12.5 Ono Pharmaceutical Recent Developments
10.13 Merck
10.13.1 Merck PD-1 and PDL-1 Inhibitors Basic Information
10.13.2 Merck PD-1 and PDL-1 Inhibitors Product Overview
10.13.3 Merck PD-1 and PDL-1 Inhibitors Product Market Performance
10.13.4 Merck Business Overview
10.13.5 Merck Recent Developments
10.14 Shanghai Junshi Bioscience Co. Ltd
10.14.1 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
10.14.2 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
10.14.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
10.14.4 Shanghai Junshi Bioscience Co. Ltd Business Overview
10.14.5 Shanghai Junshi Bioscience Co. Ltd Recent Developments
10.15 Shanghai Henlius Biotech
10.15.1 Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Basic Information
10.15.2 Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Product Overview
10.15.3 Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Product Market Performance
10.15.4 Shanghai Henlius Biotech Business Overview
10.15.5 Shanghai Henlius Biotech Recent Developments
10.16 Inc.
10.16.1 Inc. PD-1 and PDL-1 Inhibitors Basic Information
10.16.2 Inc. PD-1 and PDL-1 Inhibitors Product Overview
10.16.3 Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
10.16.4 Inc. Business Overview
10.16.5 Inc. Recent Developments
10.17 Jiangsu HengRui Medicine Co.
10.17.1 Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Basic Information
10.17.2 Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Product Overview
10.17.3 Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Product Market Performance
10.17.4 Jiangsu HengRui Medicine Co. Business Overview
10.17.5 Jiangsu HengRui Medicine Co. Recent Developments
10.18 Ltd.
10.18.1 Ltd. PD-1 and PDL-1 Inhibitors Basic Information
10.18.2 Ltd. PD-1 and PDL-1 Inhibitors Product Overview
10.18.3 Ltd. PD-1 and PDL-1 Inhibitors Product Market Performance
10.18.4 Ltd. Business Overview
10.18.5 Ltd. Recent Developments
11 PD-1 and PDL-1 Inhibitors Market Forecast by Region
11.1 Global PD-1 and PDL-1 Inhibitors Market Size Forecast
11.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
11.2.3 Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region
11.2.4 South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PDL-1 Inhibitors by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global PD-1 and PDL-1 Inhibitors Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of PD-1 and PDL-1 Inhibitors by Type (2025-2032)
12.1.2 Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of PD-1 and PDL-1 Inhibitors by Type (2025-2032)
12.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Application (2025-2032)
12.2.1 Global PD-1 and PDL-1 Inhibitors Sales (K MT) Forecast by Application
12.2.2 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
